[Federal Register Volume 63, Number 28 (Wednesday, February 11, 1998)]
[Notices]
[Page 6934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3385]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Drug Control Research, Data, and Evaluation Committee (DCRDEC);
Notice of Forthcoming Meeting
SUMMARY: This notice announces a forthcoming meeting of the Drug
Control Research, Data, and Evaluation Committee of the Office of
National Drug Control Policy.
Date, time and place. February 26, 1998, 9:00 a.m., Office of
National Drug Control Policy, Executive Office of the President, 750
17th Street, N.W., Washington, D.C.
Type of meeting and contact person. Open public meeting, 9:00 a.m.
to 2:00 p.m., unless public participation does not last that long; open
committee discussion, 9:00 a.m. to 1:30 p.m.; Janie Dargan, ONDCP,
(202) 395-6714. Persons intending to attend the meeting should arrive
in advance and come to 7th Floor Security with identification; the
meeting will take place on a secure floor of the building.
General function of the committee. The Committee provides an avenue
of communication by which a distinguished group of experts representing
scientific, engineering, law enforcement, treatment, and associated
international scientific communities advise the Director of the Office
of National Drug Control Policy (ONDCP) on questions related to
national drug control research. The Committee assists ONDCP in
identifying gaps in current data collection to improve the generation
of accurate and useful information on which to base national drug
control policy.
Agenda--Open public meeting. Interested persons may present data,
information, or views, orally or in writing, on issues of national drug
control research and policy, pending before the Committee.
Specifically, the Committee will discuss finalizing edits to a draft
Report on recommendations to ONDCP regarding the agency's national data
policy priorities, including how to better integrate drug information
for more effective drug control policy. The Committee will also be
briefed on new scientific technologies, research, and drug data policy
initiatives conducted by ONDCP and the other Federal drug-control
agencies. Those desiring to make formal presentations must notify the
contact person before February 19, 1998, and submit a brief statement
of the general nature of the evidence or arguments they wish to
present, the names and addresses of proposed participants, and an
indication of the approximate time required to make their comments.
Open committee discussion. The Committee will discuss and advise
ONDCP regarding the following: (1) final edits to the Report from the
Drug Control Research, Data, and Evaluation Committee; (2) the Counter
Technology Assessment Center's Subcommittee on Science and Technology
presentation of the TRI-Net PROJECT (formerly the DENS STUDY); (3)
discussion of HHS's expansion of the National Household Survey on Drug
Abuse (NHSDA), and a research study conducted by the Substance Abuse,
and Mental Health Services Administration (SAMHSA), to identify
treatment in correctional facilities; and (4) ONDCP's performance
measurement system.
The agenda, the questions to be addressed by the committee, and a
current list of committee members will be available at the meeting
location on the day of the meeting. Transcripts of the meeting may be
requested in writing from the Executive Office of the President, Office
of National Drug Control Policy, FOIA Requests, Office of Legal
Counsel, 750 17th Street, N.W., Washington, D.C. 20503, approximately
15 working days after the meeting, at a cost of 10 cents per page. The
transcript may be viewed at the Office of National Drug Control Policy,
Office of Legal Counsel at the above indicated address. Summary minutes
of the meeting may be requested in writing from the Freedom of
Information Office (address above) beginning approximately 90 days
after the meeting.
This notice is issued under section 10 (a)(1) and (a)(2) of the
Federal Advisory Committee Act (5 U.S.C. app. 2), and 41 CFR 101-6, et
seq., the Federal regulations on advisory committees.
Judith Leonard,
Acting General Counsel.
[FR Doc. 98-3385 Filed 2-10-98; 8:45 am]
BILLING CODE 3180-02-P
